- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05490706
The Influence of Different At-home Exercise Strategies on 24h Glycemic Control
May 12, 2023 updated by: Jenna Gillen, University of Toronto
The Influence of Different At-home Exercise Strategies on 24h Glycemic Control in Women at Risk for With Metabolic Disease
This study will determine how different at-home exercise strategies influence 24hr glycemic control in women with metabolic dysfunction.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Elevations in blood glucose concentration increase risk for cardiometabolic diseases including type 2 diabetes and cardiovascular diseases.
Exercise can improve glycemic control, but there is limited research comparing the effectiveness of different exercise strategies in women.
The aim of this study is to examine, under free-living conditions, how performing either walking and bodyweight interval exercise after dinner influences glycemic control in women with or at risk for type 2 diabetes.
Glycemic control will be measured with continuous glucose monitors.
Study Type
Interventional
Enrollment (Actual)
107
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5S1A1
- University of Toronto
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Females
- no cancer history
- ≥50 years old
- Have metabolic dysfunction (defined as self-reported diagnosis of pre-diabetes, type 2 diabetes, or at least moderate Canadian diabetes risk (CANRISK) score)
- Owns a smartphone with Bluetooth capability with Apple or Android operating system
- deemed safe to exercise as per the CSEP Get Active Questionnaire
- Enrolled in NCT05454943
Exclusion Criteria:
- Type 1 diabetes
- Taking exogenous insulin, sulfonylureas, or GLP-1 receptor agonists
- Self-reported history of an eating disorder
- BMI <18.5 kg/m
- Working night or rotating shifts
- Eating window <12 hours or consistently eating less than 3 meals/day in the past 3 months
- Major dietary changes within the past 3 months (i.e. calorie counting, ketogenic diet)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Bodyweight interval exercise
Performing 15 minutes of bodyweight interval exercise after dinner
|
Performing 15 minutes of bodyweight interval exercise after dinner at home by following a video
|
|
Experimental: Walking
Performing a 30 minute walk after dinner
|
Performing a 30 minute minute walk after dinner at home
|
|
No Intervention: Non exercise control
Performing no exercise after dinner
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
24hr Glucose area under the curve
Time Frame: 24 hours
|
Glucose area under the curve over 24hr
|
24 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
24hr Average glucose concentration
Time Frame: 24 hours
|
Average glucose concentration over 24 hr
|
24 hours
|
|
Postprandial dinner glucose response
Time Frame: 2 hours
|
Measured as the 2hr postprandial glucose incremental area under the curve (iAUC), average glucose and peak glucose
|
2 hours
|
|
Postprandial breakfast glucose response
Time Frame: 2 hours
|
Measured as the 2hr postprandial iAUC, average glucose and peak glucose
|
2 hours
|
|
Postprandial lunch glucose response
Time Frame: 2 hours
|
Measured as the 2hr postprandial glucose iAUC, average glucose and peak glucose
|
2 hours
|
|
Nocturnal glucose
Time Frame: ~6-8 hours
|
Measured as the overnight glucose average and AUC
|
~6-8 hours
|
|
Time in hyperglycemia
Time Frame: 24 hours
|
Time (minutes and percent per day) above 10mmol/L over 24hr
|
24 hours
|
|
Time in hypoglycemia
Time Frame: 24 hours
|
Time (minutes and percent per day) under 3.9mmol/L over 24 hr
|
24 hours
|
|
Time in range
Time Frame: 24 hours
|
Time (minutes and percent per day) above 3.9 but under 10mmol/L
|
24 hours
|
|
Continuous overall net glycemic action (CONGA)
Time Frame: 24 hours
|
Calculated measure of glycemic variability
|
24 hours
|
|
Change in glucose during exercise
Time Frame: 15-30 minutes
|
Post vs. pre glucose concentration around exercise
|
15-30 minutes
|
|
Mean amplitude glycemic excursion (MAGE)
Time Frame: 24 hours
|
Calculated measure of glycemic variability
|
24 hours
|
|
Standard deviation (SD)
Time Frame: 24 hours
|
Calculated measure of glycemic variability
|
24 hours
|
|
% coefficient of variation (CV)
Time Frame: 24 hours
|
Calculated measure of glycemic variability
|
24 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jenna Gillen, PhD, University of Toronto
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 7, 2022
Primary Completion (Actual)
April 30, 2023
Study Completion (Actual)
April 30, 2023
Study Registration Dates
First Submitted
July 29, 2022
First Submitted That Met QC Criteria
August 4, 2022
First Posted (Actual)
August 8, 2022
Study Record Updates
Last Update Posted (Actual)
May 15, 2023
Last Update Submitted That Met QC Criteria
May 12, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 42756-2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Metabolic Disturbance
-
The Swedish School of Sport and Health SciencesActive, not recruiting
-
University of WashingtonNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Appalachian State UniversityAGRANACompletedMetabolic Disturbance | Permeability; IncreasedUnited States
-
Northumbria UniversityCompletedMetabolic Disturbance | Dietary ExposureUnited Kingdom
-
Appalachian State UniversityCompletedGastrointestinal Dysfunction | Metabolic DisturbanceUnited States
-
University of TorontoWomen's College HospitalCompleted
-
University of TorontoCanadian Institutes of Health Research (CIHR)RecruitingSedentary Behavior | Metabolic DisturbanceCanada
-
Northumbria UniversityUnknownMetabolic Disturbance | Dietary ExposureUnited Kingdom
-
University of NottinghamCompletedObesity | Metabolic DisturbanceUnited Kingdom
Clinical Trials on Bodyweight interval exercise
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloCompleted
-
St. Olavs HospitalNorwegian University of Science and TechnologyCompletedTachycardia, Ventricular | Defibrillators, ImplantableNorway
-
Rigshospitalet, DenmarkCompleted
-
Edward Via Virginia College of Osteopathic MedicineAuburn UniversityCompletedResistance TrainingUnited States
-
Holy Name Medical Center, Inc.BiogenUnknown
-
University of GuelphCompletedPost-Exercise Hypotension | Ambulatory Blood Pressure Monitoring | High-intensity Interval ExerciseCanada
-
Ahlia UniversityCairo UniversityCompletedObesity | Diabetes | Exercise | Nonalcoholic Fatty Liver DiseaseEgypt
-
Hywel Dda Health BoardCompletedChronic Obstructive Airway Disease | Neutrophil Function DisorderUnited Kingdom
-
Laboratoire des Adaptations Métaboliques à l'Exercice...CREPS Auvergne Rhône-Alpes / VichyCompletedOverweight | PostmenopausalFrance